| Literature DB >> 21311588 |
.
Abstract
Health systems research and development is needed to support the global malaria eradication agenda. In this paper, we (the malERA Consultative Group on Health Systems and Operational Research) focus on the health systems needs of the elimination phase of malaria eradication and consider groupings of countries at different stages along the pathway to elimination. We examine the difference between the last attempt at eradication of malaria and more recent initiatives, and consider the changing health system challenges as countries make progress towards elimination. We review recent technological and theoretical developments related to health systems and the renewed commitment to strengthening health systems for universal access and greater equity. Finally, we identify a number of needs for research and development, including tools for analyzing and improving effective coverage and strengthening decision making and discuss the relevance of these needs at all levels of the health system from the community to the international level.Entities:
Mesh:
Year: 2011 PMID: 21311588 PMCID: PMC3026705 DOI: 10.1371/journal.pmed.1000397
Source DB: PubMed Journal: PLoS Med ISSN: 1549-1277 Impact factor: 11.069
Figure 1Health system building blocks [.
Image credit: Fusión Creativa.
Figure 2Graphical representation of the systems effectiveness framework.
How interventions lose traction in health systems: example of artemisinin-based combination therapy (ACT) antimalarial treatment in Rufiji Demographic Surveillance Area Tanzania in 2006. Source: INDEPTH INESS Project. Systems Effectiveness Module, Swiss Tropical and Public Health Institute with data from Ifakara Health Institute and US Centers for Disease Control and Prevention based on [45]–[47]. Image credit: Fusión Creativa.
Categorization of the malERA health systems research goals and approaches.
| Categories | Goals/Problems | Means/Approaches | Cross-Cutting | Stage of Elimination/Eradication |
|
| Reduce unacceptable and avoidably low effective coverage of essential malaria interventions. | Develop/validate toolkit for owning, analyzing, and responding to system-level bottlenecks in intervention delivery and use. | Yes, drugs, vaccines, vector control, diagnostics. | Scaling-up, sustained control, preelimination, and elimination. |
| Harness a community of health systems analysts into the malaria elimination community. | Assess other models of global disease elimination enterprises to develop an optimal approach to an appropriately widened community. | Yes. | Scaling-up, sustained control, preelimination and elimination, prevention of reintroduction | |
| Understand how and facilitate strengthening of health systems by disease-specific global health initiatives in malaria. | Assist global health initiatives to apply systems science to guide health system strengthening investments. | Yes, concerns all agendas. | Scaling-up, sustained control, preelimination, and elimination. | |
|
| Facilitate policy decision uncertainty for when to commit to transitioning from control to elimination phase and understand how disease-specific global health investments in malaria strengthen health systems and facilitate it. | Develop systems dynamic modeling, tools and case studies to understand determinants for elimination go-no/go policy decisions. | Yes, concerns all agendas. | Scaling-up, sustained control and preelimination, elimination. |
| Determine whether the kind and mix of integrated interventions are cost-effective in differing epidemiologic and health system contexts. | Develop system dynamic modeling and respective tools as well as case studies to assess synergies. | Yes, drugs, vaccines, vector control. | Control, preelimination, elimination. | |
|
| Communicate determinants of successful regional and intercountry collaboration for disease elimination | Critical review and analysis. | No. | Elimination. |
| Major increase in community and district engagement and ownership of the malaria-control and elimination agenda. | Develop means to engage communities more effectively in case management, vector control, and surveillance. | Yes, drugs, vaccines, vector control, surveillance. | Control, preelimination, elimination. |
Matrix of health systems research and development needs.
| Level/Building Block | Governance | Human Resources | Financing | Information | Service Delivery, Medicines, and Technology |
|
| How can lay boards (community leader councils) strengthen local health service delivery? (Group 1 countries) | What is the role of CHWs and private sector providers in treatment of malaria and nonmalaria fevers, and in what settings are they crucial? | What are the main financial (and other) barriers to health services use and how can these be overcome? | What is the best approach to community-based monitoring of malaria and other communicable diseases building on existing and past efforts? | How can the community components of integrated approaches (IMCI and IMAI) be strengthened and adapted to different epidemiological and system settings? |
| What is the role of communities in active efforts at transmission reduction (as opposed to reducing morbidity and mortality from malaria)? | How can they be incentivized and integrated with the health system to support and sustain their performance? | — | How can health information systems include information from and to CHWs? (Group 1 countries) | — | |
|
| Tools for assessing illicit payment for services | What are the most effective and appropriate methods for monitoring health worker performance? | — | How can modeling and evaluation innovations for malaria eradication strengthen health systems? | Development of IMCI and IMAI updated with new diagnostic tools and adapted to the malaria elimination context |
| — | What types of financial and nonfinancial incentives can best support and sustain improved health worker performance? | — | Tools for assessing local coverage, quality, and equity to apply to systems effectiveness framework | Development of appropriate multidisease diagnostic tools | |
| — | — | — | — | Tools for drugs and supplies stock management | |
|
| What model(s) for district management of malaria-control programmes are effective in achieving and maintaining near zero malaria burden en route to elimination? | What are the appropriate organization and management, skill mix, human resource structure, and enabling factors to support effective service delivery? | Tools for developing efficient decentralized decision making and administration | How do we engage private providers and capture their data? | How can private provider involvement in case management, surveillance and vector control be harnessed? |
| — | — | — | How can district managers be supported to use the systems effectiveness framework and tools to remove bottlenecks in service delivery? | How can data for decision-making skills be taught such that responses to resurgences in malaria burden are swiftly responded to? | |
|
| What investment and tools will ensure the quality of governance and accountability required for malaria elimination? (Groups 2 and 3). | What experience is there of strengthening health worker motivation and performance through disease-specific programmes, especially looking at global elimination initiatives (positive synergies)? | What financial resources will be required to manage the certification process at subnational and national levels? (Groups 2 and 3). | What experience is there of strengthening health management information systems through disease-specific programmes, especially looking at global elimination initiatives (positive synergies)? | What is the cost-effectiveness of different delivery modes in different national/subnational settings (e.g., community strategy versus facility, integrated curative services versus specialized, integrated vector management) malaria vector control; operations research on effect of scale on optimal organizational structures? |
| What governance structures are required to manage the elimination certification process? | — | What financing mechanisms are optimal at the national level to ensure a predictable and sustained flow of resources for malaria elimination? (Group 2) | — | What experience is there of strengthening service delivery and logistics/distribution chains through disease-specific programmes, especially looking at global elimination initiatives (positive synergies)? | |
| What experience is there of strengthening health system governance through disease-specific programmes, especially looking at global elimination initiatives (positive synergies). | — | — | — | — | |
| Tools to identify and evaluate possible interventions required in health system governance | — | — | — | — | |
|
| What are the determinants of successful intercountry collaboration on shared public health targets? | Tools: development of better regional training | — | — | What are the strengths and weaknesses of current malaria surveillance and case-management practices in endemic countries belonging to group 2? |
|
| Does the formulation of time-specific malaria elimination targets strengthen the participation of public and private stakeholders? | — | What are the macroeconomic benefits of malaria elimination? (Group 3) | — | What are the local geographic, economic, ecological, cultural determinants of malaria, and community and health system response? Includes operations research on service provision for mobile and marginalized populations |
| — | — | — | — | What architecture and dynamics of complex intersectoral intervention strategies are required to achieve a major, sustainable, and cost-effective city-wide impact on persistent urban malaria? |
Group 1, countries that are scaling up and entering the sustained control phase, where most of the population lives in areas where malaria elimination is considered impossible with existing tools; group 2, countries with focal malaria, where a large part of the population lives in malaria-free areas, and where health systems strengthening could play a crucial role in interrupting transmission in many but not necessarily all of the existing foci. These are often countries with very diverse and complex health systems challenges; group 3, elimination-ready countries. When a group of countries is not indicated, the text applies to group 1 and group 2 countries alike.
Responsibility for these issues shared with malERA Monitoring, Evaluation, and Surveillance group.
IMAI, integrated management of adult and adolescent illness; IMCI, integrated management of childhood illness.